Express News | Kaisheng New Materials: The controlling Shareholder plans to issue no more than 1 billion yuan of exchangeable CSI Enterprise bonds.

BreakingsDec 11 15:56

Huapont Life Sciences (002004.SZ): Plans to privately issue no more than 1 billion yuan of exchangeable bonds.

Gelonghui, December 10 - huapont life sciences (002004.SZ) announced that the company will hold the 21st meeting of the 8th board of directors on December 10, 2024, to review and approve relevant proposals including "Proposal on the Company's Compliance with Conditions for Private Placement of Exchangeable Corporate Bonds", "Proposal on the Company's Private Placement Plan for Exchangeable Corporate Bonds", and "Proposal to Authorize the Board of Directors to Handle All Matters Related to this Private Placement of Exchangeable Corporate Bonds". Taking into full consideration the company's global strategy and combining the company's actual situation, the company intends to privately place exchangeable bonds to professional institutional investors.

Gelonghui FinanceDec 10 16:47

Express News | huapont life sciences: Wholly-owned subsidiary huapont pharmaceutical obtained the pharmaceutical registration certificate for Benidipine hydrochloride tablets.

BreakingsDec 6 16:13

Express News | Huapont Life Sciences establishes a new technology company with multiple AI businesses.

BreakingsNov 8 13:39

Huapont Life Sciences (002004.SZ): has repurchased 0.35% of shares accumulated.

On November 1, Eguo.com reports: Huapont Life Sciences (002004.SZ) announced that, as of October 31, 2024, the company has repurchased a total of 6,959,908 shares through centralized trading, accounting for 0.35% of the company's current total share capital. The highest fill price was 4.65 yuan/share, the lowest fill price was 3.84 yuan/share, and the total amount paid was 29.4993 million yuan (excluding trading fees).

Gelonghui FinanceNov 1 15:48

Huabang Health: Report for the third quarter of 2024

SZSIOct 29 00:00 · Announcements